Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thorn

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics|September 21, 2015
Validation of the Hospital Episode Statistics Outpatient Dataset in EnglandJoanna C Thorn, Emma Turner, Luke Hounsome, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 12, 2019
Recurrence patterns identify aggressive form of human papillomavirus-dependent vulvar cancerRebekah E McWhirter, Petr Otahal, Debbie Taylor-Thomson, et al.
Scandinavian Journal of Immunology|June 26, 2001
In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapyM Rygg, C M Uhlar, C Thorn, et al.
Biophysical Chemistry|February 5, 2021
Native disulphide-linked dimers facilitate amyloid fibril formation by bovine milk α<sub>S2</sub>-caseinDavid C Thorn, Elmira Bahraminejad, Aidan B Grosas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Pharmacoeconomics|June 25, 2021
Aspects and Challenges of Resource Use Measurement in Health Economics: Towards a Comprehensive Measurement FrameworkLuca M M Janssen, Ruben M W A Drost, Aggie T G Paulus, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
Protein Science : a Publication of the Protein Society|July 23, 2020
Cumulative deamidations of the major lens protein γS-crystallin increase its aggregation during unfolding and oxidationCalvin J Vetter, David C Thorn, Samuel G Wheeler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Applied Health Economics and Health Policy|January 9, 2023
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUMIrina Pokhilenko, Luca M M Janssen, Aggie T G Paulus, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|September 21, 2015
Validation of the Hospital Episode Statistics Outpatient Dataset in EnglandJoanna C Thorn, Emma Turner, Luke Hounsome, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 12, 2019
Recurrence patterns identify aggressive form of human papillomavirus-dependent vulvar cancerRebekah E McWhirter, Petr Otahal, Debbie Taylor-Thomson, et al.
Scandinavian Journal of Immunology|June 26, 2001
In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapyM Rygg, C M Uhlar, C Thorn, et al.
Biophysical Chemistry|February 5, 2021
Native disulphide-linked dimers facilitate amyloid fibril formation by bovine milk α<sub>S2</sub>-caseinDavid C Thorn, Elmira Bahraminejad, Aidan B Grosas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Pharmacoeconomics|June 25, 2021
Aspects and Challenges of Resource Use Measurement in Health Economics: Towards a Comprehensive Measurement FrameworkLuca M M Janssen, Ruben M W A Drost, Aggie T G Paulus, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
Protein Science : a Publication of the Protein Society|July 23, 2020
Cumulative deamidations of the major lens protein γS-crystallin increase its aggregation during unfolding and oxidationCalvin J Vetter, David C Thorn, Samuel G Wheeler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Applied Health Economics and Health Policy|January 9, 2023
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUMIrina Pokhilenko, Luca M M Janssen, Aggie T G Paulus, et al.
Pageof 9